FPT-DEUTSCHLAND-GMBH
3.11.2021 08:02:14 CET | Business Wire | Press release
FPT Europe, a subsidiary of the global technology services provider FPT Corporation, has become a strategic partner for E.ON Group in the area of digital transformation and SAP IDM Managed Services. According to the five-year contract, FPT will support E.ON on both legacy and new SAP environments at the corporate-wide level. The project will be delivered with FPT's best-shore model as SAP experts from FPT Germany (onsite), FPT Slovakia (nearshore) and the offshore delivery team in Vietnam will work together to assure the timely manner in responding to customer’s requests, provide excellent services with no communication barrier and time zone difference.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211103005041/en/
Tailor-made services
Within the contract framework, FPT provides administration and maintenance of SAP functions in the Governance, Risk Management and Compliance (GRC) Operations. In addition, the IT experts manage user access authorizations through systematic User Authorization Management, develop and manage user roles as part of service Role Administration & Development. Moreover, FPT provides Security, Data Protection, Audit & Compliance Support as well as handles all related on-call Duty services.
By working with FPT, E.ON benefits from an optimized service delivery model and experienced technology experts who speak local language. The newly-signed contract also proves FPT’s outstanding service-level agreement which complies with the European General Data Protection Regulation.
FPT as a trusted partner in SAP for large enterprises
"In the course of the supplier consolidation and process optimization around SAP Identity @ Access Management, FPT was selected as our future supplier within the scope of a tender. The offer itself and the transition approach corresponded to what we as E.ON expect.
The operational topics of incident management and role building were awarded for a variety of SAP environments. Additional agreed services are in areas of audit and ICS/SOD support as well as application support for SAP IDM @ GRC Technology.
Past experience has shown that FPT has knowledge in most areas and is therefore also able to serve the E.ON world. The new topics were tackled quickly by FPT, and the transition phase is well progressed.
The aim is to have FPT on board as a reliable and SLA-loyal partner in this area from 01.11.2021. For the start of this managed service, we wish a lot of success, a motivated team and a good cooperation." summarized Dieter Bürgel, Head of Corporate Digital Services at E.ON the support engagement with FPT.
"This contract with E.ON demonstrates our ability to provide application managed services to large enterprises in Germany and Europe," said Le Hai, CEO of FPT Europe. "The key factor for success lies in the expertise and experience of our experts in SAP IDM Managed Services. We also effectively apply the best-shore model by combining our talent pools in Germany and Slovakia with the delivery team in Vietnam to achieve competitive advantages."
"We made great effort to find solutions to the difficulties encountered in preparing for this important contract," affirmed Andy Do, Deputy Director/ Head of Delivery at FPT Europe. "In particular, we invested early in recruiting experts for our Center of Excellence and trained our current employees to improve their SAP IDM Managed Services skills. And with all of this good preparation, we prove that FPT is able to meet the customer's high requirements and successfully win their trust."
About FPT Deutschland GmbH
Headquartered in Essen, Germany, FPT Deutschland GmbH is part of FPT Corporation, a technology and IT services provider headquartered in Vietnam with 36,000 employees and revenues of approximately $2 billion. As the pioneer in digital transformation, the company offers world-class services in smart factory, digital platforms, RPA (robotic process automation), artificial intelligence (AI), IoT (Internet of Thing), Data Analytics, Mobility, Cloud, Managed Services And Testing. FPT Software serves more than 700 customers worldwide, including 100 of which are Fortune 500 companies in the Aerospace, Automotive, Banking And Finance, Communications, Media And Services, Logistics And Transportation, Utilities, Consumer Products, Healthcare, Manufacturing, Public Sector, Technology, etc. Founded in 2012, FPT Europe is a technology partner of 50 leading companies, including RWE, Allianz, Siemens, Schaeffler, Airbus and Carlsberg,etc. For more information, visit: www.fpt-europe.de .
About E.ON
E.ON is a privately owned international energy company headquartered in Essen, Germany, that focuses on the business areas of energy networks and customer solutions. As one of the largest energy companies in Europe, E.ON plays a leading role in shaping a green, digital and decentralized energy world. Around 75,000 employees develop and sell products and solutions for residential, commercial and industrial customers. More than 50 million customers purchase electricity, gas, digital products or solutions for electromobility, energy efficiency and climate protection from E.ON. As an innovation leader, E.ON offers its customers the latest technology solutions and promotes cross-industry partnerships in the energy sector and beyond. More information at www.eon.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005041/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom